April 2011, Vol 2, No 2

Successful Strategies for Drug Cost-Containment in Oncology Practice

HOPA Conference, Oncology Practice

April 2011, Vol 2, No 2

Preparing for Future Trends in Cancer Care

ACCC Conference

April 2011, Vol 2, No 2

NCCN Expert Panel Considers Value, Utilization of Molecular Testing in Clinical Practice

By Lee N. Newcomer, MD, MHA

NCCN Conference

April 2011, Vol 2, No 2

Prominent Oncologist Applauds First Conference of the Association of Value-Based Cancer Care

April 2011, Vol 2, No 2

Interview with Al B. Benson, III, MD, FACP

Peginterferon Alfa-2b for Metastatic Melanoma after Definitive Surgical Resection

FDA Approvals, News & Updates

April 2011, Vol 2, No 2

Sorafenib Active Third-Line in Refractory GIST

By Caroline Helwick

Genitourinary Cancers Symposium

April 2011, Vol 2, No 2

Hypertension a Good Sign in Patients Receiving Sunitinib

Genitourinary Cancers Symposium

April 2011, Vol 2, No 2

Future of Colorectal Cancer Therapy: Novel Targeted Pathways

By Caroline Helwick

Colorectal Cancer, Genitourinary Cancers Symposium

April 2011, Vol 2, No 2

Competing Tests for Colorectal Cancer Risk Recurrence

By Caroline Helwick

Colorectal Cancer, Genitourinary Cancers Symposium

April 2011, Vol 2, No 2

Making Cancer Drugs Worth the Cost

By Christin Melton

HOPA Conference

April 2011, Vol 2, No 2

Page 1 of 3

1
2
3